Skip to main content
. 2023 Dec 13;11(2):649–661. doi: 10.1002/ehf2.14560

Figure 3.

Figure 3

Obesity and heart failure with preserved ejection fraction (HFpEF). The figure shows the clinical feature and pathophysiology of obesity and HFpEF and the potential benefit deriving from glucagon‐like peptide‐1 receptor agonists. LV, left ventricular.